We are live on ! Find out more
TBPH icon

Theravance Biopharma
TBPH

119 hedge funds and large institutions have $696M invested in Theravance Biopharma in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 39 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

709% more call options, than puts

Call options by funds: $13.2M | Put options by funds: $1.63M

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

8.28% more ownership

Funds ownership: 83.85% → 92.13% (+8.3%)

7% more capital invested

Capital invested by funds: $648M → $696M (+$48.4M)

0% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 39

3% less funds holding

Funds holding: 123 → 119 (-4)

14% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 21

Holders
119
Holders Change
-4
Holders Change %
-3.25%
% of All Funds
1.91%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
18
Increased
39
Reduced
39
Closed
21
Calls
$13.2M
Puts
$1.63M
Net Calls
+$11.6M
Net Calls Change
+$6.3M

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.28M
2
Two Sigma Investments
Two Sigma Investments
New York
+$3.26M
3
BlackRock
BlackRock
New York
+$2.35M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$2.15M
5
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$1.28M

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$21M
2
NM
Newtyn Management
New York
-$11M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$4.7M
4
RCMNY
Rubric Capital Management (New York)
New York
-$3.61M
5
C
Chescapmanager
Maryland
-$3.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
126
Sagefield Capital
Texas
– -$523K -51,600 Closed
HF
127
HRT Financial
New York
– -$502K -49,596 Closed
Simplex Trading
128
Simplex Trading
Illinois
– -$505K -48,092 Closed
CC
129
Centiva Capital
New York
– -$419K -41,300 Closed
BFM
130
Boothbay Fund Management
New York
– -$360K -35,477 Closed
AG
131
Algert Global
California
– -$311K -30,700 Closed
LSA
132
Leonteq Securities AG
Switzerland
– -$291K -28,726 Closed
XT
133
XTX Topco
Cayman Islands
– -$207K -20,410 Closed
COPPSERS
134
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$167K -16,437 Closed
CL
135
CSS LLC
Illinois
– -$153K -15,000 Closed
Canada Pension Plan Investment Board
136
Canada Pension Plan Investment Board
Ontario, Canada
– -$96K -9,500 Closed
Group One Trading
137
Group One Trading
Illinois
– -$37.9K -3,608 Closed
PA
138
Parallel Advisors
California
– -$2K -215 Closed
CA
139
Crewe Advisors
Utah
– -$1K -131 Closed
BIA
140
Bell Investment Advisors
California
– -$1K -50 Closed
2 3 4 5
6

TBPH Hedge Fund Activity: Q4 2022 in Review

119 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Theravance Biopharma (TBPH) for Q4 2022, worth a combined $696M — up 7.5% from $648M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of TBPH and 18 opened new positions — a net loss of 3 holders — while 39 trimmed existing stakes and 39 added.

The largest buyer was Two Sigma Advisers, adding an estimated $3.28M. The largest seller was Baupost Group, cutting an estimated $21M.

  • 119 institutional investors held Theravance Biopharma (TBPH) as of Q4 2022, down from 123 in Q3 2022.
  • Funds reported $696M of Theravance Biopharma stock for Q4 2022, up 7.5% quarter-over-quarter.
  • 18 funds opened new Theravance Biopharma positions in Q4 2022 and 21 closed out, a net change of -3 holders.
  • The largest Theravance Biopharma buyer in Q4 2022 was Two Sigma Advisers, an estimated $3.28M added.
  • The largest Theravance Biopharma seller in Q4 2022 was Baupost Group, an estimated $21M sold.

Based on aggregated 13F filings for Q4 2022.